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ABSTRACT
The development of an aorta-atrial fistula secondary to mechanical aortic valve infective endocarditis is a rare, serious complication. The fistula is an aberrant intra-cardiac
shunt that occurs between the aorta and either the left or right atrium. An aorta-atrial
fistula can be congenital or acquired. In the case of infective endocarditis, the infection’s
expansion beyond the valvular structure may result in an aorto-cavitary fistula (ACF or
AAF) with an estimated incidence of 1-2%.1 No clinical trials have been conducted for
the best approach of management for this condition. Therefore, treatment strategies are
applied on a case-by-case basis by expert opinion. Patients develop symptoms of heart
failure secondary to AAF complications. The underlying cause of AAF needs to be identified with the use of imaging studies to determine the approach of optimal treatment.2
We are reporting a case of a 32-year-old male with a history of repaired congenital heart
disease, who developed mechanical aortic valve infective endocarditis from intravenous
drug use with subsequent development of an aorta-atrial fistula.
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A 32-year-old male with a past medical history of
congenital aortic stenosis presented to the hospital
with two weeks of fever. At the age of 8, he underwent open aortic valvotomy with resection of a
subaortic ring and myomectomy. Three years prior
to the current presentation, he was diagnosed with
severe aortic insufficiency and underwent re-entry
median sternotomy, resection of the subaortic ring,
left ventricular septal myotomy-myomectomy, reconstruction of left ventricular outflow tract with On-X 23
mm Dacron valve conduit, re-implantation of left and
right coronary ostia, replacement of the ascending
aorta, and tricuspid valve repair using a 32 mm triad
annuloplasty ring procedure. Gross description in
the operative report disclosed findings of a bicuspid
structural valve. On the pathology report, fibromyxoid degenerative changes of the valvular leaflets were
found.
At presentation to the outside facility, he had complaints of bilateral lower extremity weakness, vision
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changes, fever, chills, myalgias, and malaise for two
weeks. Per patient report, he had used suboxone
intravenously. The TEE showed an abscess with complete destruction of the left ventricular outflow track
with a shunt of the LVOT to the left atrium, destruction of the aortic root, and a large anterior leaflet
aortic valve vegetation. The CT head revealed bilateral occipital lobe hemorrhages and a large 3.7cm
left occipital lobe hematoma. There was mass-effect
and cerebral edema, but no midline shift. Therefore,
he was diagnosed with an ischemic stroke due to
septic emboli with hemorrhagic conversion. His INR
was supratherapeutic at 5.9, which was reversed after
receiving KCENTRA and Vitamin K. He was seen by
neurosurgery who recommended no surgical intervention and to hold anticoagulation. CT chest reported evidence of systemic embolization. Vancomycin
was started with rifampin for synergy. The patient was
transferred from the outside hospital to a higher level
of care for evaluation by cardiothoracic surgery after
being diagnosed with complicated MRSA mechanical
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and possible abscess
was reported with no
evidence of dissection.
Infectious disease was
consulted and adjusted
antimicrobial therapy
due to persistent MRSA
bacteremia. After evaluation, the cardiothoracic
surgeon decided that
the patient was a poor
surgical candidate
and recommended to
continue antibiotics and
consult palliative care.

Figure 1: Transesophageal echocardiogram view 1: LA left
atrium, LV left ventricle, fistula between aorta and left atrium
(yellow arrow).

aortic valve endocarditis.
After cardiothoracic surgery
evaluation, the TTE was repeated, which showed a fistula
between the LVOT, proximal
to AOV, and left atrium. The
patient had a normal EF but
the mechanical aortic valve
was noted to have moderate
to severe stenosis without
regurgitation. A small aortic
vegetation was also reported.
For further evaluation, a TEE
was performed which revealed
restricted rocking, suggestive
of valve dehiscence with moderate aortic regurgitation, and
a large fistula between the aorta and left atrium (Figure 1-2).
Also, a valve vegetation with a
possible thrombus was noted. An aortic root vegetation
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The patient’s clinical
condition began to deteriorate and show signs
of acute CHF. He was
transferred to the critical
care unit due to worsening respiratory failure.
Repeat TTE showed findings similar to previous findings with grade three diastolic heart failure. ProBNP
was 5725, and a repeat CT chest revealed worsening
bilateral pleural effusions. Intravenous diuretics were
started, and thoracenteses were performed twice

Figure 2: Transesophageal echocardiogram view 2: doppler color flow
from the aorta to the left atrium through the fistula (Yellow arrow).
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due to large pleural effusions. However, the patient
continued to decline, was given comfort care, and
passed away.
DISCUSSION
An aorto-atrial fistula, caused by infective endocarditis, is due to the spread of the bacterial infection to
the peri-valvular tissue. This leads to the destruction
of the tissue and weakness of the wall integrity of
the aorta and atrium, causing fistula formation.3 In a
retrospective multicenter study, aorto-cavity fistula
(ACF) is diagnosed in 1.6% of all cases of IE either
identified by echocardiography or during surgery.
A fistula was found in 1.8 % of cases of native valve
IE, in 3.5% of prosthetic valves IE from the general
population, and in 0.4% of IV drug abusers. Fistula
formation only occurred in the aortic valves with IE
and more frequently in prosthetic valves than native
valves (5.8 vs. 3.6 % respectively).3
In a retrospective, multi-center study, the most commonly isolated organism in fistula formation was the
staphylococcus species, as seen in 58% of cases with
prosthetic valve and 38 % with a native valve. Staphylococcus aureus was the most single common cause
of fistula formation among patients with a native
valve. Other pathogens included streptococcus spp.
(33%), Enterococcus spp. (5%), and culture-negative
pathogens (7%).3
Imaging studies play a major role in the assessment
of fistula. In a retrospective, descriptive, multi-center
study, the TTE detected fistula formation in 53% of
cases, but the TEE detected 97% of cases, conveying
the superiority of TEE over TTE.3 AAF usually occurs
on the posterior aspect of the aorta, which is an area
better delineated with the TEE than the TTE1. Standard antimicrobial therapy and surgical intervention
are the cornerstones of treating IE complicated by
AAF. A high index of suspicion and early treatment
of the fistula is crucial. Heart failure was observed in
62% of cases, and the in-hospital mortality was 41%3.
Heart failure is caused by the hemodynamic abnormality created by the shunt. Left ventricular function,
however, can still remain normal.3
Although acquired AAF is uncommon in patients
with IE, with the increasing rates of IVDU in the US,
the incidence of acquired AAF may increase. From
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2002 to 2016, the reported rates of IE due to intravenous drug use have doubled.4 This case is unique,
as the patient already had a congenital defect of his
aortic valve requiring mechanical valve replacement,
which was then complicated by IE from his IVDU. Patients with an intravenous substance use disorder, or
with a history of underlying congenital heart disease
or previous cardiac surgery who develop IE are more
likely to have an elevated risk of developing AAF with
an increased risk of adverse outcomes.
CONCLUSION
An aorto-atrial fistula as the result of infective endocarditis is an uncommon complication. Early diagnosis, proper antibiotic treatment, and surgical intervention are crucial steps due to high morbidity and
mortality rate.5
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